Skip to content

Estradiol

Estradiol is a form of estrogen, a key hormone in the regulation of the female reproductive system and secondary sexual characteristics. It plays a crucial role in bone density, cardiovascular health, and cognitive function, making it significant for longevity and health optimization, particularly in postmenopausal women.

Intelligence Profile

Research Papers

Key Research Papers and Clinical Trials

The current research on estradiol spans several areas, though the available evidence is limited and focuses primarily on preclinical studies and specific clinical applications.

Preclinical Research

Recent laboratory studies have explored estradiol's biological mechanisms, particularly in metabolic processes. One study published in the Journal of Biological Chemistry examined how estrogen promotes glucose metabolism through specific cellular pathways in chicken follicular cells, providing insights into estradiol's role in energy metabolism at the cellular level.

Additional preclinical work has investigated estradiol in the context of reproductive toxicology, with computational modeling studies examining how certain chemicals may disrupt estradiol and other hormone pathways. However, these are modeling studies rather than direct clinical investigations of estradiol therapy.

Clinical Trial Evidence

The clinical trial landscape for estradiol shows ongoing but limited research:

Reproductive Medicine Applications: A Phase 2 trial is examining estradiol combined with progesterone for luteal phase support in IVF/ICSI cycles, comparing this approach to GnRH agonist treatment. Another study is investigating estradiol valerate combined with letrozole for treating polycystic ovarian syndrome, though recruitment has not yet begun.

Cardiovascular and Metabolic Effects: A completed Phase 2 trial studied hormonal regulation of circulating endothelial cells and HDL cholesterol in men, though specific results are not available from the provided evidence.

Postmenopausal Applications: A Phase 3 trial is examining estrogen plus estradiol receptor modulators for oxidative stress in postmenopausal women, particularly those with sleep apnea, though the current status is unclear.

Evidence Limitations

The available research evidence is quite limited, with most studies being either preclinical investigations or clinical trials without reported outcomes. The human clinical data is primarily from ongoing or completed trials without published results in the provided evidence. More comprehensive clinical research would be needed to draw definitive conclusions about estradiol's therapeutic applications.

This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider for personalized medical guidance.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.